Location History:
- Granger, IN (US) (2011 - 2016)
- South Granger, IN (US) (2016)
Company Filing History:
8 out of 370 
3 out of 146 
Years Active: 2011-2016
Title: Mark A Suckow: Innovator in Vaccine Adjuvants and Cancer Treatment
Introduction
Mark A Suckow is a notable inventor based in Granger, Indiana, with a significant contribution to the fields of vaccine development and cancer treatment. He holds a total of eight patents, showcasing his innovative approach to addressing critical health challenges.
Latest Patents
Among his latest patents, Suckow has developed extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins. This patent discloses vaccines and adjuvants that are useful in the treatment and prevention of infections, such as tetanus, and diseases related to biological toxins. The methods provided include preparing an adjuvant and the vaccine containing it, as well as techniques for vaccinating animals against these infections. The adjuvant materials are derived from extracellular matrix materials and have been shown to enhance the immunogenicity of antigens, improving the survival rates of immunized animals.
Another significant patent focuses on metastasis inhibition preparations and methods. This invention includes compositions and pharmaceutical preparations designed to inhibit the metastasis of malignant cancers in animals. The methods outlined in this patent aim to inhibit or eliminate metastasis, particularly in cases of malignant prostate cancer. The preparations may include whole cell tumor preparations comprising tumor tissue cells and connective tissue stroma, demonstrating promising results in vivo.
Career Highlights
Suckow has worked with esteemed institutions such as the University of Notre Dame Du Lac and Cook Biotech, Inc. His work in these organizations has allowed him to advance his research and contribute to significant innovations in medical science.
Collaborations
Throughout his career, Suckow has collaborated with notable colleagues, including William R Wolter and Paul J Hall. These collaborations have further enriched his research and development efforts.
Conclusion
Mark A Suckow's contributions to vaccine adjuvants and cancer treatment exemplify his commitment to innovation in the medical field. His patents reflect a deep understanding of complex biological processes and a dedication to improving health outcomes.